Select Page

eBooks

by AplusA

Sharing valuable healthcare market insights that support our clients to make strategic business decisions is the cornerstone of what we do at APLUSA. Our eBooks share data from syndicated trackers and demonstrate the types of insights we deliver as part of our market studies.

eBOOKS

by AplusA

Sharing valuable healthcare market insights that support our clients to make strategic business decisions is the cornerstone of what we do at APLUSA. Our eBooks share data from syndicated trackers and demonstrate the types of insights we deliver as part of our market studies.

HEMOPHILIA A&B

The eBook provides key learnings from a Syndicated Tracker, it includes these following points:

  • Hemophilia Disease Management: The switching between prophylaxis and on-demand treatment. Extended vs. standard half-life.
  • Hemophilia Products: Is there a difference among recombinants?
  • Product Performance: Patient shares of leading hemophilia products and classes. Product switching. Developmental therapies.
  • Treatment Considerations: What attributes governed hematologists choice? How do hematologists treat inhibitor patients?
Hemophilia A&B eBook

DIFFUSE LARGE B-CELL LYMPHOMA

The eBook provides a comprehensive market overview for marketers or market researchers working in this area. It includes:

  • Market background overview
  • Treatment performance as revealed by our tracker
  • Patient insights
  • Social media listening patient journey insights
DLBCL eBook

Performance Trackers

Download our free eBook for insights on the following topics:

  • Aligning stakeholder objectives

  • Organising a successful RFP

  • Writing a winning brief

  • Selecting a market research agency

DLBCL eBook

TRACKING MULTIPLE MYELOMA

Using results from AplusA’s syndicated multiple myeloma tracker, this eBook answers the following questions:

  • What are the key benefits of a patient chart syndicated tracker?
  • What brand performance insights does this Multiple Myeloma tracker provide?
  • What business-essential patient insights does the tracker provide?
  • What does the tracking study reveal about multiple myeloma market dynamics?

 

Augmented Insights: ASCO 2019

Which topics, pharmaceutical companies, organizations and HCPs had the most digital impact?

This eBook provides insights on:

    • A look at the most active social media accounts during the event
    • The topics most discussed by HCPs, companies, and healthcare organizations
    • The most impactful KOLs
    • The opinions of 50 French hematologists

Hemato-Oncology: Key Points

Treatment Options and Key Stakeholders

Based on APLUSA research, this free eBook provides you with an overview of the key stakeholders and treatment options available for four of the most common malignancies in hemato-oncology:

  • Chronic lymphocytic leukemia (CLL)
  • Acute myeloid leukemia (AML)
  • Diffuse large B-Cell lymphoma (DLBCL)
  • Multiple myeloma (MM)

Let’s talk!

Interested in finding out more?
Contact our team via the link below and we’ll be delighted to send over more information about our services or to discuss a specific project you are working on.

Skip to content